Recent 8-K filings for NGNE

Each filing is summarized by an LLM — headline, three bullets, event type. The source document on EDGAR is one click away. See methodology.

• May 12, 2026 20:06 UTC earnings item 2.02item 9.01

  Neurogene reports Q1 net loss $30.9M; ~90% dosed in Rett gene therapy trial, cash runway to Q1 2028

source · NGNE on sec.gov